Publication at First Faculty of Medicine |
2021
Abstract
COVID-19 has ravished the world, with secondary consequences that are not yet possible to estimate. WHO and the European Extracorporeal Life Support Organization (ELSO) recommended extracorporeal membrane oxygenation (ECMO) early in the pandemic, according to the standard criteria.
In March, 2020, the EuroELSO survey was established to report the use of ECMO and outcomes in patients with COVID-19 once per week.